Metabolic and Kidney Disorders Correlate with High Atazanavir Concentrations in HIV-Infected Patients: Is It Time to Revise Atazanavir Dosages?

INTRODUCTION: Ritonavir-boosted atazanavir (ATV/r) is a relatively well tolerated antiretroviral drug. However, side effects including hyperbilirubinemia, dyslipidemia, nephrolithiasis and cholelithiasis have been reported in the medium and long term. Unboosted ATV may be selected for some patients...

Full description

Saved in:
Bibliographic Details
Published in:PLoS One
Main Authors: Gervasoni, Cristina, Meraviglia, Paola, Minisci, Davide, Ferraris, Laurenzia, Riva, Agostino, Landonio, Simona, Cozzi, Valeria, Charbe, Nitin, Molinari, Lara, Rizzardini, Giuliano, Clementi, Emilio, Galli, Massimo, Cattaneo, Dario
Format: Artigo
Language:Inglês
Published: Public Library of Science 2015
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4398451/
https://ncbi.nlm.nih.gov/pubmed/25875091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0123670
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items